BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24054957)

  • 1. Effective reduction of blood product use in a community teaching hospital: when less is more.
    Politsmakher A; Doddapaneni V; Seeratan R; Dosik H
    Am J Med; 2013 Oct; 126(10):894-902. PubMed ID: 24054957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
    Metz J; McGrath KM; Copperchini ML; Haeusler M; Haysom HE; Gibson PR; Millar RJ; Babarczy A; Ferris L; Grigg AP
    Med J Aust; 1995 Jun; 162(11):572-3, 576-7. PubMed ID: 7791642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.
    Sarode R; Refaai MA; Matevosyan K; Burner JD; Hampton S; Rutherford C
    Transfusion; 2010 Feb; 50(2):487-92. PubMed ID: 19804569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation.
    Zilberberg MD; Shorr AF
    BMC Health Serv Res; 2007 Aug; 7():138. PubMed ID: 17764560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
    Butler CE; Noel S; Hibbs SP; Miles D; Staves J; Mohaghegh P; Altmann P; Curnow E; Murphy MF
    Transfusion; 2015 Aug; 55(8):1964-71. PubMed ID: 25906831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction.
    Riskin DJ; Tsai TC; Riskin L; Hernandez-Boussard T; Purtill M; Maggio PM; Spain DA; Brundage SI
    J Am Coll Surg; 2009 Aug; 209(2):198-205. PubMed ID: 19632596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year clinical audit of the use of blood and blood components at a tertiary hospital in Nigeria.
    Arewa OP
    Niger J Clin Pract; 2009 Dec; 12(4):429-33. PubMed ID: 20329686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms.
    Tuckfield A; Haeusler MN; Grigg AP; Metz J
    Med J Aust; 1997 Nov; 167(9):473-6. PubMed ID: 9397061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of education and computerized decision support interventions for improving transfusion practice.
    Rothschild JM; McGurk S; Honour M; Lu L; McClendon AA; Srivastava P; Churchill WH; Kaufman RM; Avorn J; Cook EF; Bates DW
    Transfusion; 2007 Feb; 47(2):228-39. PubMed ID: 17302768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to NICU transfusion guidelines: data from a multihospital healthcare system.
    Baer VL; Lambert DK; Schmutz N; Henry E; Stoddard RA; Miner C; Wiedmeier SE; Burnett J; Eggert LD; Christensen RD
    J Perinatol; 2008 Jul; 28(7):492-7. PubMed ID: 18337739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
    Rosenberg EM; Chambers LA; Gunter JM; Good JA
    Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin reduces the need for blood products during liver transplantation.
    Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
    Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the utilization of blood components in San Pablo Hospital; 1991-1996.
    Hunter Mellado R
    Bol Asoc Med P R; 1997; 89(1-3):4-8. PubMed ID: 9168628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective audit program to determine blood component transfusion appropriateness at a large university hospital: a 5-year experience.
    Jackson GN; Snowden CA; Indrikovs AJ
    Transfus Med Rev; 2008 Apr; 22(2):154-61. PubMed ID: 18353254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive transfusion--evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern England.
    Rose AH; Kotzé A; Doolan D; Norfolk DR; Bellamy MC
    Vox Sang; 2009 Oct; 97(3):247-53. PubMed ID: 19497086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do we reduce plasma transfusion in Rhode Island?
    Nixon CP; Tavares MF; Sweeney JD
    Transfusion; 2017 Aug; 57(8):1863-1873. PubMed ID: 28681548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion audit of fresh-frozen plasma in southern Taiwan.
    Yeh CJ; Wu CF; Hsu WT; Hsieh LL; Lin SF; Liu TC
    Vox Sang; 2006 Oct; 91(3):270-4. PubMed ID: 16958841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing red cell transfusion by audit, education and a new guideline in a large teaching hospital.
    Garrioch M; Sandbach J; Pirie E; Morrison A; Todd A; Green R
    Transfus Med; 2004 Feb; 14(1):25-31. PubMed ID: 15043590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [To inadequate indication of blood transfusion in a reference hospital in Lima, Peru].
    Flores-Paredes W
    Rev Peru Med Exp Salud Publica; 2011 Dec; 28(4):617-22. PubMed ID: 22241257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
    Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL;
    J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.